Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

OSL/MEDI stock hub

OSL/MEDI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/MEDIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1B

Oslo Børs

Market data

Live price

Current market quote for this ticker.

Current price

OSL/MEDI

In the news

Latest news · OSL/MEDI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.9

P25 20.7P50 25.9P75 44.9

Trailing P/E26.5

P25 21.8P50 45.3P75 75.4

ROE32.1

P25 -70.7P50 -18.3P75 4.1

ROIC51.4

P25 -76.9P50 -12P75 2.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/MEDI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

NOK

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	159
Employees Change	5%
Employees Change Percent	3.25
Enterprise value	NOK 4B
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Medical Devices
Isin	NO0010159684
Last refreshed	2026-05-10
Market cap	NOK 4.1B
Price	NOK 226
Price currency	NOK
Rev Per Employee	4,527,584.91x
Sector	Healthcare
Sic	3845
Symbol	osl/MEDI
Website	https://www.medistim.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.78%
EV Earnings	25.37x
EV/EBIT	20.4x
EV/EBITDA	18.93x
EV/FCF	23.29x
EV/Sales	5.5x
FCF yield	4.11%
Forward P/E	25.85x
P/B ratio	8.16x
P/E ratio	26.49x
P/S ratio	5.74x
PE Ratio10 Y	38.86x
PE Ratio3 Y	33.15x
PE Ratio5 Y	42.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.96%
EBITDA Margin	27.83%
FCF margin	23.61%
Gross margin	80.71%
Gross Profit	NOK 581.1M
Gross Profit Growth	27.33%
Gross Profit Growth Q	24.34%
Gross Profit Growth3 Y	14.6%
Gross Profit Growth5 Y	15.37%
Net Income	NOK 156.1M
Net Income Growth	53.33%
Net Income Growth Q	78.81%
Net Income Growth Quarters	5%
Net Income Growth Years	2%
Net Income Growth3 Y	11.79%
Net Income Growth5 Y	18.07%
Pretax Margin	28.01%
Profit Margin	21.68%
Profit Per Employee	NOK 981,635
Profitable Years	19
ROA	18.68
Roa5y	18.02
ROCE	35.15
ROE	32.08
Roe5y	30.66
ROIC	51.38
Roic5y	44.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	18.46%
Cagr15y	19.92%
Cagr1y	42.48%
Cagr20y	18.44%
Cagr3y	-5.19%
Cagr5y	-1.88%
Div CAGR10	17.1%
Div CAGR3	21.14%
Div CAGR5	6.83%
EPS Growth	53.63
EPS Growth Q	79.83
EPS Growth Quarters	5
EPS Growth Years	1
EPS Growth3 Y	11.76
EPS Growth5 Y	18.04
FCF Growth	32.51%
FCF Growth Q	-5.66%
FCF Growth3 Y	20.32%
FCF Growth5 Y	22.18%
OCF Growth	30.73%
OCF Growth Q	-6.01%
OCF Growth10 Y	15.4%
OCF Growth3 Y	18.13%
OCF Growth5 Y	20.34%
Revenue Growth	24.38x
Revenue Growth Q	20.61x
Revenue Growth Quarters	8x
Revenue Growth Years	5x
Revenue Growth3 Y	12.9x
Revenue Growth5 Y	14.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 1.11
Assets	NOK 681.9M
Cash	NOK 209.8M
Current Assets	NOK 477.7M
Current Liabilities	NOK 143.2M
Debt	NOK 34.6M
Debt EBITDA	NOK 0.17
Debt Equity	NOK 0.07
Debt FCF	NOK 0.2
Equity	NOK 506.7M
Interest Coverage	43.04
Liabilities	NOK 175.1M
Long Term Assets	NOK 204.2M
Long Term Liabilities	NOK 31.9M
Net Cash	NOK 175.2M
Net Cash By Market Cap	NOK 4.24
Net Cash Growth	12.41%
Net Debt EBITDA	NOK -0.87
Net Debt Equity	NOK -0.35
Net Debt FCF	NOK -1.03
Tangible Book Value	NOK 405M
WACC	9.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.8
Inventory Turnover	0.85
Net Working Capital	NOK 152.7M
Quick ratio	2.56
Working Capital	NOK 362.4M
Working Capital Turnover	NOK 2.19

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.21%
Dividend Growth	33.33%
Dividend Growth Years	1%
Dividend per share	NOK 8
Dividend Years	22
Dividend Yield	3.54%
Ex Div Date	2026-05-07
Last Dividend	NOK 8
Payout Frequency	Annual
Payout Ratio	70.13%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	443.87%
1Y total return	42.44%
200-day SMA	235.9
3Y total return	-14.77%
50-day SMA	220.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-9.06%
All Time High	409
All Time High Change	-44.74%
All Time High Date	2021-09-02
All Time Low	9
All Time Low Change	2,411.11%
All Time Low Date	2004-10-15
ATR	8.04
Beta	1.01
Beta1y	0.19
Beta2y	0.24
Ch YTD	-12.74
High	237
High52	292
High52 Date	2025-10-28
High52ch	-22.6%
Low	224
Low52	165
Low52 Date	2025-05-08
Low52ch	36.97%
Ma50ch	2.65%
Price vs 200-day SMA	-4.18%
RSI	50.25
RSI Monthly	52
RSI Weekly	49.65
Sharpe ratio	0.96x
Sortino ratio	1.86
Total Return	3.75%
Tr YTD	-9.57
Tr15y	1,425.47%
Tr1m	10.48%
Tr1w	2.28%
Tr3m	9.45%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK 194.1M
Operating Income Growth	49.68
Operating Income Growth Q	63.76
Operating Income Growth3 Y	11.58
Operating Income Growth5 Y	15.49
Operating margin	26.96

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,315,780%
Net Borrowing	-9,357,000
Shares Insiders	10.15%
Shares Institutions	77.58%
Shares Out	18,292,836
Shares Qo Q	0%
Shares Yo Y	-0.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK 170M
Average Volume	22,050.75x
CAPEX	NOK -5.5M
Ch10y	336.7
Ch15y	904.4
Ch1m	6.6
Ch1w	-1.31
Ch1y	32.55
Ch20y	1,514.3
Ch3m	5.61
Ch3y	-22.6
Ch5y	-19.86
Ch6m	-6.61
Change	-0.88%
Change From Open	-4.64
Close	228
Days Gap	3.95
Depreciation Amortization	7,202,000
Dollar Volume	5,853,400
Earnings Date	2026-04-14
EBIT	NOK 194.1M
EBITDA	NOK 200.4M
F Score	6
FCF	NOK 170M
FCF EV Yield	4.29x
FCF Per Share	NOK 9.29
Financing CF	-116,260,000
Fiscal Year End	December
Founded	1,984
Goodwill	14,128,000
Income Tax	NOK 45.6M
Investing CF	-35,168,000
Is Primary Listing	1
Last Earnings Date	2026-04-14
Last Report Date	2025-12-31
Ma150	234.6
Ma150ch	-3.69%
Ma20	230.4
Ma20ch	-1.89%
Net CF	26,337,000
Next Earnings Date	2026-08-19
Open	237
P FCF Ratio	24.32
P OCF Ratio	23.56
Payment Date	2026-05-18
Position In Range	15.38
Ppne	79,386,000
Price Date	2026-05-08
Price EBITDA	NOK 20.63
Ptbv Ratio	10.21
Relative Volume	1.17x
Revenue	719,886,000x
Tax By Revenue	6.33x
Tax Rate	22.6%
Tr20y	2,849.89%
Tr6m	-3.22%
Volume	25,900

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

OSL/MEDI dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.5%

$8.00 annual per share

Payout ratio

+70.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.8%

1 consecutive years of growth

Total shareholder yield

+3.7%

Next ex-dividend date: 2026-05-07

Performance

OSL/MEDI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OSL/MEDI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.6%

Share of float held by funds and institutions

Insider ownership

+10.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

OSL/MEDI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.3

Neutral momentum band

Price vs 200-day MA

-4.2%

50/200-day relationship not available

Beta (5Y)

1.01

Moves roughly with the market

Sharpe ratio

0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/MEDI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/MEDI stock rating?

osl/MEDI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/MEDI analysis?

The full report lives at /stocks/osl/MEDI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/MEDI?

The latest report frames osl/MEDI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/MEDI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.